Complement Decay-Accelerating Factor | | Target | Disease | Rheumatoid Arthritis | | | | | | |
Doxacurium Chloride | | Drug | Disease | Hypotension | | | | | | |
464.1 | | Target | Disease | Hypotension | | | | | | |
Complement Decay-Accelerating Factor | | Target | Disease | Arthritis | | | | | | |
Aralen (Chloroquine)- FDA | | Drug | Disease | Arthritis | | | | | | |
ALK Phos | | Target | Disease | Liver Disease | | | | | | |
AMAC-1 | | Target | Disease | Inflammation | | | | | | |
Eotaxin-2/CCL24 | | Target | Disease | Inflammation | | | | | | |
ALK Phos | | Target | Disease | Cholesterol | | | | | | |
Kaad-Cyclopamine | | Drug | Disease | Carcinoma | | | | | | |
Aralen (Chloroquine)- FDA | | Drug | Disease | Shock | | | | | | |
Kaad-Cyclopamine | | Drug | Disease | Prostate Cancer | | | | | | |
Doxacurium Chloride | | Drug | Disease | Depression | | | | | | |
Doxacurium Chloride | | Drug | Disease | Stroke | | | | | | |
AMAC-1 | | Target | Disease | Rheumatoid Arthritis | | | | | | |
Aralen (Chloroquine)- FDA | | Drug | Disease | Rheumatoid Arthritis | | | | | | |
Eotaxin-2/CCL24 | | Target | Disease | Rheumatoid Arthritis | | | | | | |
Kaad-Cyclopamine | | Drug | Disease | Cancer | | | | | | |
Amitiza (Lubiprostone)- FDA | | Drug | Disease | Pain | | | | | | |
Kaad-Cyclopamine | | Drug | Disease | Breast Cancer | | | | | | |
Kallikrein-8 | | Target | Disease | Breast Cancer | | | | | | |
Kaad-Cyclopamine | | Drug | Disease | Lung Cancer | | | | | | |
Kallikrein-8 | | Target | Disease | Lung Cancer | | | | | | |
464.1 | | Target | Disease | Asthma | | | | | | |
Kallikrein-8 | | Target | Disease | Inflammation | | | | | | |
AMAC-1 | | Target | Disease | Arthritis | | | | | | |
Complement Decay-Accelerating Factor | | Target | Target | Collagen | | | | | | |
ALK Phos | | Target | Target | Collagen | | | | | | |
Eotaxin-2/CCL24 | | Target | Target | Collagen | | | | | | |
Kallikrein-8 | | Target | Target | Collagen | | | | | | |
Aralen (Chloroquine)- FDA | | Drug | Disease | Stroke | | | | | | |
Complement Decay-Accelerating Factor | | Target | Disease | Leukemia | | | | | | |
464.1 | | Target | Disease | Leukemia | | | | | | |
Kallikrein-8 | | Target | Disease | Leukemia | | | | | | |
ALK Phos | | Target | Disease | Hepatitis | | | | | | |
AMAC-1 | | Target | Disease | Breast Cancer | | | | | | |
Aralen (Chloroquine)- FDA | | Drug | Disease | Breast Cancer | | | | | | |
ALK Phos | | Target | Disease | Breast Cancer | | | | | | |
464.1 | | Target | Disease | Cholesterol | | | | | | |
Complement Decay-Accelerating Factor | | Target | Disease | Inflammation | | | | | | |
464.1 | | Target | Disease | Inflammation | | | | | | |
ALK Phos | | Target | Disease | Inflammation | | | | | | |
Tegument Protein Vp16 | | Target | Disease | Inflammation | | | | | | |
Aralen (Chloroquine)- FDA | | Drug | Disease | Infection | | | | | | |
Aralen (Chloroquine)- FDA | | Drug | Disease | Pain | | | | | | |
Mu-Type Opioid Receptor | | Target | Disease | Pain | | | | | | |
ALK Phos | | Target | Disease | Pain | | | | | | |
Tegument Protein Vp16 | | Target | Disease | Pain | | | | | | |
Complement Decay-Accelerating Factor | | Target | Disease | Cancer | | | | | | |
Complement Decay-Accelerating Factor | | Target | Disease | Infection | | | | | | |